Since it has recently been revealed that loss of CLCA2 promotes the epithelial to mesenchymal transition (EMT) in breast cancer cells [28], we next examined whether the transcriptional profile of EMT markers might be changed in SCC of the lung using data from the TCGA database. The gene discussed is CLCA2; the disease is breast cancer.